Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006 May 10;295(18):2164-2167.
Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009 Mar;18(3):784-791.
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009 Aug 15;115(16):3801-3807.
International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 2009 Jul;20(5):525-531.
Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006. Eur Arch Otorhinolaryngol 2011 Jun;268(6):899-906.
Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 2011 Feb;21(2):125-134.
Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis. Eur J Epidemiol 2012 Aug;27(8):615-622.
AJCC Staging Manual. Springer; 2017. p. 1024
Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992 Dec;164(6):658-661.
Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993 Dec;114(6):1050-1057.
2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2016 Jan;26(1):1-133.
The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 2011 Mar;21(3):231-236.
Defining a valid age cutoff in staging of well-differentiated thyroid cancer. Ann Surg Oncol 2016 Feb;23(2):410-415.
Identifying the most appropriate age threshold for TNM stage grouping of well-differentiated thyroid cancer. Eur J Surg Oncol 2015 Aug;41(8):1028-1032.
An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer. Thyroid 2016 Mar;26(3):373-380.
Exploring the relationship between patient age and cancer-specific survival in papillary thyroid cancer: rethinking current staging systems. J Clin Oncol 2016 Dec 20;34(36):4415-4420.
2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid Cancer. Thyroid 2016 Jan;26(1):1-133.
Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf) 2014 Jul;81 Suppl 1:1-122.
AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States. Surgery 2004 Sep;136(3):609-616.
Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 1996 Nov;3(6):534-538.
Comparable outcomes for patients with pT1a and pT1b differentiated thyroid cancer: Is there a need for change in the AJCC classification system? Surgery 2014 Dec;156(6):1484-1489.
The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer. Surgery 2011 Dec;150(6):1242-1249.
Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. Am J Surg 1993 Oct;166(4):331-335.
Operative management of locally advanced, differentiated thyroid cancer. Surgery 2016 Sep;160(3):738-746.
Risk factor analysis in differentiated thyroid cancer. Cancer 1979 Mar;43(3):810-820.
Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 1996 Mar-Apr;18(2):127-132.
Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg 2012 Apr;255(4):777-783.
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006 Feb;16(2):109-142.
The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension ata surgical affairs committee's taskforce on thyroid cancer nodal surgery. Thyroid 2012 Nov;22(1):1144-1152.
The impact of metastatic lymph nodes on risk stratification in differentiated thyroid cancer: have we reached a higher level of understanding? Thyroid 2016 Apr;26(4):481-488.
Observation of clinically negative central compartment lymph nodes in papillary thyroid carcinoma. Surgery 2013 Dec;154(6):1166-1172.
Controversies about the central compartment in thyroid cancer. Editorial regarding the article “Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 cases” by Alexandre Bozec et al. Eur Arch Otorhinolaryngol 2011 Aug;268(8):1097-1099.
Central compartment dissection for well differentiated thyroid cancer ... and the band plays on. Curr Opin Otolaryngol Head Neck Surg 2011 Apr;19(2):106-112.
Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection. Br J Surg 2016 Feb;103(3):218-225.
An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988 Dec;104(6):947-953.
A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid cancer cooperative group. Eur J Cancer 1979 Aug;15(8):1033-1041.
Iodine or Not (IoN) for low-risk differentiated thyroid cancer: the next UK National Cancer Research Network randomised trial following HiLo. Clin Oncol (R Coll Radiol) 2012 Apr;24(3):159-161.
Strategies of radioiodine ablation in patients with low-risk thyroid cancer. N Engl J Med 2012 May 03;366(18):1663-1673.
The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification. Thyroid 2013 Jun;23(6):683-694.
Selective use of radioactive iodine in intermediate-risk papillary thyroid cancer. Arch Otolaryngol Head Neck Surg 2012 Dec 1;138(12):1141-1146.
Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) 1977 May;56(3):171-196.
Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987 Dec;102(6):1088-1095.
Surgery for papillary thyroid carcinoma: is lobectomy enough? Arch Otolaryngol Head Neck Surg 2010 Nov;136(11):1055-1061.
Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery 2012 Apr;151(4):571-579.
Thyroid lobectomy is associated with excellent clinical outcomes in properly selected differentiated thyroid cancer patients with primary tumors greater than 1 cm. J Thyroid Res 2013;2013:398194.
The British Association of Endocrine & Thyroid Surgeons Fourth National Audit Report: Dendrite Clinical Systems Ltd, The Hub, Station Road, Henley-on-Thames, Oxfordshire RG9 1AY: United Kingdom; 2012.
Well differentiated thyroid cancer: Are we over treating our patients? Eur J Surg Oncol 2014 Feb;40(2):129-132.
, Ferris RL, Goldenberg D, Haymart M, Shaha A, Sheth S, Sosa JA, Tufano RP; American Thyroid Association Surgical Affairs Committee. American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid 2012 May;22(5):501-508.